viral
respir
ectian
repres
signific
segment
total
respiratori
diseas
speclrum
howev
reeentl
laboralori
diagnosi
oj
viral
respiratori
infect
relalir
im
f
icient
develop
new
hnprove
immunolog
assay
system
pave
way
accur
reliabl
rapid
diagnost
test
detect
viral
antigen
clinic
specialen
conduct
care
elabor
studi
radioimmunoassay
antigen
detect
compar
u
batteri
tissu
cultur
system
viral
isol
identi
tcati
use
ltne
plastic
cathet
specimen
mucu
aspir
nasopharynx
patient
clinic
sign
symptom
acut
viral
upper
respiratori
tract
infect
spechnen
divid
two
portion
one
use
inocul
varieti
tissu
cultur
cell
line
use
radioimmunoassay
test
influenza
b
adenaviru
parainfluenza
respiratori
syncyti
viru
radioimmunoassav
result
campar
favor
tissu
cultur
data
onv
one
exceptionadenoviru
essenti
degre
accuraci
reproduc
obtain
enzrnleliak
imnmnosorb
assay
test
replac
radioimmunoassar
tissu
cultur
still
use
backup
rapid
antigen
detect
system
place
coupl
modern
comput
program
ta
facilit
laboratori
data
clinician
consider
stride
hare
nlade
continu
made
diagnosi
therapi
viral
respirat
r
tract
infect
diagnosi
viral
infect
respiratori
tract
rel
ineffici
due
sever
factor
one
isol
viru
tissu
cultur
system
agent
rhinoviru
coronaviru
cultiv
practic
manner
other
respiratori
syncyti
viru
low
rate
effici
cultiv
anoth
factor
qualiti
specimen
presenc
viral
immunoglobulin
aantibodi
mucu
secret
viru
inactiv
due
improp
storag
prolong
transport
time
specimen
laboratori
third
factor
relat
prospect
viru
present
specimen
exampl
case
influenza
chanc
isol
agent
decreas
rapidli
day
onset
clinic
symptom
final
time
requir
viru
isol
includ
tissu
cultur
cultiv
hemadsorpt
type
viru
isol
gener
requir
day
time
laps
toler
use
cooper
clinician
maintain
enhanc
effici
perform
rapid
diagnosi
current
tool
clinic
virolog
first
success
effort
direct
made
gardner
mcquillin
london
grandien
stockholm
halonen
et
al
turku
other
orstavik
et
al
berg
et
al
chao
et
al
daisi
et
al
fulton
middleton
scientist
improv
applic
immunofluoresc
techniqu
rapid
diagnosi
respiratori
tract
diseas
view
european
group
rapid
viral
diagnosi
reason
progress
rapid
diagnosi
viral
diseas
although
immunofluoresc
stain
cell
remov
nasopharynx
rapid
method
also
subject
requir
highli
skill
microscopist
prepar
smear
usual
bedsid
anoth
critic
problem
furthermor
method
autom
restrict
rel
small
number
sampl
per
day
therefor
advantag
radioimmunoassay
ria
enzymelink
immunosorb
assay
elisa
yolken
clearli
evid
major
advantag
object
high
sensit
detect
specif
viral
antigen
independ
presenc
viabl
viru
purcel
et
al
last
advantag
elimin
problem
storag
transport
sampl
well
diagnost
problem
later
cours
ill
recent
studi
shown
sensit
specif
elisa
ria
compar
obtain
immunofluoresc
tec
aniqu
convent
isol
techniqu
minnich
ray
sarkkinen
et
al
sarkkinen
et
al
valid
rapid
diagnosi
respiratori
tract
viral
diseas
test
antigen
detect
pilot
project
outbreak
berlin
winter
ria
elisa
perform
accord
method
sarkkinen
et
al
sarkkinen
et
al
sarkkinen
et
al
halonen
et
al
purpos
studi
test
effici
fourlay
ria
enzym
immunoassay
respect
comparison
convent
isol
techniqu
routin
work
laboratori
unselect
clinic
specimen
time
pilot
project
character
outbreak
influenza
subtyp
h
follow
second
wave
subtyp
within
wk
season
outbreak
acut
respiratori
diseas
specimen
patient
investig
influenza
b
para
respiratori
syncyti
adenoviru
ehrlich
et
al
specimen
obtain
hospit
patient
patient
see
physician
clinic
offic
patient
mainli
children
sex
rang
age
wk
yr
clinic
symptom
acut
respiratori
diseas
examin
within
first
day
onset
clinic
symptom
sampl
obtain
aspir
nasopharynx
fine
plastic
cathet
nostril
patient
method
usual
ml
mucu
easili
obtain
furthermor
learn
method
readili
toler
patient
throat
swab
vomit
stimulu
avoid
handl
aspir
specimen
divid
two
part
one
dilut
eagl
medium
contain
antibiot
inocul
tissu
cultur
primari
african
green
monkey
kidney
cell
human
diploid
fibroblast
fl
cell
tissu
cell
observ
cytopath
effect
hemadsorpt
posit
propag
deembryon
egg
examin
electron
microscop
second
part
specimen
dilut
phosphat
buffer
salin
contain
fc
tween
merthiol
sonic
dissolv
mucu
materi
store
test
ria
elisa
procedur
ria
perform
polystyren
bead
coat
antiviru
guinea
pig
immunoglobulin
g
igg
purifi
immunosorb
chromatographi
overnight
adsorpt
sampl
prepar
rabbit
antiviru
immunoglobulin
ad
allow
react
hr
follow
addit
label
sheep
antirabbit
igg
bind
ratio
greater
compar
control
prepar
consid
posit
sensit
procedur
method
antigen
detect
determin
purifi
antigen
sensit
rang
gml
viru
protein
adenoviru
influenza
parainfluenza
gml
influenza
b
parainfluenza
respiratori
syncyti
viru
sensit
gml
specif
high
crossreact
observ
either
control
antigen
clinic
specimen
type
isol
virus
demonstr
figur
specimen
cultur
influenza
viru
neg
tissu
cultureposit
ria
four
tissu
cultureneg
posit
six
cultureposit
neg
ria
result
independ
influenza
subtyp
investig
show
ria
good
sensit
enhanc
effici
obtain
ria
viabl
viru
escap
detect
ria
small
number
present
specimen
influenza
b
viru
ria
significantli
higher
effici
convent
isol
techniqu
howev
adenoviru
figur
tissu
cultureneg
attempt
also
neg
ria
tissu
cultureposit
specimen
three
neg
ria
signific
improv
diagnosi
could
obtain
respiratori
syncytia
viru
figur
cultureneg
probe
five
significantli
figur
influenza
antigen
detect
radioimmunoassay
tissu
cultureposit
specimen
tissu
cultureneg
specimen
ehrlich
et
al
figur
z
adenoviru
antigen
detect
radioimmunoassay
tissu
cultureposit
specimen
tissu
cultureneg
specimen
ehrlich
et
al
figur
respiratori
syncyti
viru
antigen
detect
radioimmunoassay
two
tissu
cultureposit
specimen
tissu
cultureneg
specimen
ehrlich
et
al
exampl
demonstr
yr
project
close
agreement
clinic
pictur
result
could
confirm
demonstr
signific
increas
antibodi
titer
case
parainfluenza
viru
infect
found
observ
period
outbreak
later
year
method
produc
good
result
high
sensit
evid
influenza
especi
influenza
b
higher
effici
viru
diagnosi
obtain
use
ria
signific
advanc
also
may
obtain
respiratori
syncyti
viru
adenoviru
ria
produc
measur
advantag
evalu
seven
test
natur
occur
epidemiolog
condit
elect
continu
approach
replac
ria
method
elisa
use
peroxidas
detect
system
microtit
plate
result
essenti
use
elisa
system
clinic
diagnost
routin
cover
nearli
hospit
larg
number
outpati
clinic
west
berlin
antigen
detect
approach
prove
suitabl
method
improv
effici
diagnosi
respiratori
virus
opinion
still
necessari
perform
tissu
cultur
simultan
sensit
enhanc
use
purifi
antibodi
higher
potenc
better
specif
activ
label
gener
monoclon
antibodi
advantag
system
concentr
sampl
import
factor
test
seven
differ
viru
antigen
requir
least
ml
mucu
would
desir
reduc
test
volum
develop
combin
test
sever
antigen
one
singl
assay
time
requir
viru
diagnosi
could
reduc
sever
day
hr
final
consid
time
reduct
diagnost
work
one
keep
mind
especi
use
rapid
method
organ
flow
clinic
materi
patient
laboratori
evalu
interpret
print
transfer
result
clinician
requir
amount
time
greater
laboratori
test
therefor
develop
fullycomputer
diagnost
system
obtain
signific
addit
time
reduct
viru
diagnosi
habermehl
habermehl
rapid
diagnosi
viru
diseas
goal
immedi
futur
current
avail
antivir
drug
specif
direct
one
group
kind
viru
therapi
start
earli
possibl
necessari
establish
varieti
diagnost
method
prepar
fulfil
clinic
requir
futur
